A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.Rosalind Glasspool, T.R. Jeffry Evans, C. A. Hopkins et al.|Journal of Clinical Oncology|2017Cited by 3
B17 IN VITRO AND IN VIVO CHARACTERIZATION OF THE VASOPRESSIN RECEPTOR ANTAGONIST SSR149415Cliona MacSweeney, Hugh Marston, Kim Anderson et al.|Behavioural Pharmacology|2005Cited by 0